Plant Comparison
Midland Hawthorn vs Lavender
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Midland Hawthorn and Lavender: they share 6 indicated uses (arthritis / joint pain, inflammation (general), insomnia / sleeplessness, …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Midland Hawthorn | Lavender | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Lavender |
| Inflammation (general) | 1/10 | 5/10 | Stronger for Lavender |
| Insomnia / sleeplessness | 1/10 | 5/10 | Stronger for Lavender |
| Menstrual cramps | 1/10 | 5/10 | Stronger for Lavender |
| Muscle spasm | 1/10 | 5/10 | Stronger for Lavender |
| Skin irritation | 1/10 | 5/10 | Stronger for Lavender |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The principal cardioactive and antioxidant constituents, the basis for extract standardisation.
Additional antioxidant constituents of the flower, leaf and fruit.
Flower essential oil dominated by linalool and linalyl acetate, the principal compounds behind the calming, anxiolytic and antimicrobial activity.
Antioxidant constituents of the flower.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally safe and well tolerated. High doses may cause low blood pressure and sedation. May interact with cardiac glycosides (digoxin) and antihypertensive drugs. Consult a physician before using with existing heart medications.
Duke (2002) rates hawthorn (Crataegus spp., including C. laevigata) as a triple-plus herb (+++) with Commission E approval (score 2-3) for decreasing cardiac output in functional Stage II heart insufficiency (NYHA). Clinical evidence supports hawthorn standardized extracts (80-500 mg, standardized to flavonoids or procyanidins) for angina, arrhythmia, atherosclerosis, and hypertension. Hawthorn may potentiate digitalis and other cardiac medications and is not considered suitable for self-medication without professional guidance (Duke, 2002).
Generally very safe. Essential oil should not be ingested in large amounts. Rarely, contact dermatitis may occur. May potentiate the effect of sedative medications. Avoid therapeutic doses during pregnancy.
Duke (2002) rates lavender as ++ and provides clinical evidence (score 2) for carminative activity, consistent with Commission E approval for nervous stomach disorders and functional abdominal complaints. Additional experimental activities include anxiolytic, antispasmodic, and antiseptic effects. The essential oil demonstrates COX-2 inhibitory and Alzheimer's-relevant properties at the experimental level. Dose: 1–2 teaspoons (4–8 g) dried flowers as tea; 1–3 drops essential oil in a carrier for topical or aromatherapy use. Duke notes that oral lavender oil (Silexan) has clinical evidence for generalized anxiety disorder (Duke, 2002).
External Ids
Botanical Description
Small deciduous tree or large shrub with thorny branches and glossy, shallowly lobed leaves (less deeply cut than common hawthorn). Clusters of small, five-petalled white (occasionally pink) flowers with a strong scent appear in spring, followed by small red berries (haws), each usually containing two seeds (nutlets).[1]
Aromatic, evergreen, woody-based perennial subshrub with narrow, grey-green, felted leaves. Slender flowering spikes carrying whorls of small, tubular, two-lipped violet-blue flowers rise well above the foliage on long, unbranched stalks.[4]
Habitat
Grows in woodland, woodland edges, hedgerows and scrub, typically on richer, damper soils than common hawthorn; native to western and central Europe.[1]
Native to the mountains of the western Mediterranean (southern France, Spain, Italy); widely cultivated in sunny, well-drained, often calcareous sites across temperate and Mediterranean climates worldwide.[4]
Harvesting
Flowers are picked as they open in spring, leaves are picked with the young flowering shoots, and the ripe red berries (haws) are gathered in autumn; all three parts are used, often combined, in hawthorn preparations.[1]
The flower spikes are cut as the flowers open, in mid- to late summer, when essential oil content is highest, and dried in a warm, shaded, airy place or distilled fresh for essential oil.[4]
Traditional Uses
Hawthorn flower, leaf and berry have a long European tradition, and substantial modern clinical study, as a cardiovascular tonic - supporting heart function, mild circulatory complaints and calming nervous tension - reflected in its traditional use for 'heart strengthening' and its modern standing as a well-studied botanical for mild heart failure symptoms.[1]
Lavender flower has a long Mediterranean and European tradition as a calming, sedative herb for nervous tension, anxiety and insomnia, and as a mild digestive carminative and antiseptic for minor wounds and skin irritation; the essential oil in particular has an extensive modern clinical evidence base for anxiety and sleep support.[4]
Preparations
Leaf-and-flower extract standardised to flavonoid or oligomeric proanthocyanidin content, taken as tablets or capsules; the best-studied clinical form.
Dosage
The EU herbal monograph on Crataegus spp., folium cum flore gives dry extracts in divided daily doses of 240-900 mg (single dose 80-450 mg) or, for one quantified extract, 570-1750 mg daily (single dose 190-350 mg), in adults and elderly. If symptoms persist longer than 2 weeks a doctor should be consulted, and hawthorn is never used as a substitute for prescribed heart medication without medical supervision. Educational reference only, not a prescription.
The EU herbal monograph gives 1-2 g of the comminuted leaf and flower in 150 mL of boiling water as an infusion, up to 4 times daily (maximum 6 g daily), in adults and elderly. Educational reference only, not a prescription.
The EU herbal monograph gives 1-2 g of the flower in 150 mL of boiling water as an infusion, three times daily, in adolescents, adults and elderly; a tincture at 2-4 mL three times daily is also listed. The monograph notes that lavender may impair the ability to drive or use machines. Not recommended under 12 years. Educational reference only, not a prescription.
References
Drug Class Interactions
Lookalikes Review
Pairings
Not documented
Lavender and valerian are both calming herbs used to aid relaxation and sleep; taken together their sedative effects can add up, so while they may help relaxation they can also increase drowsiness — avoid combining with sedative medicines or before driving.[22, 23]
Lavender and lemon balm are both calming herbs used to ease anxiety and aid sleep; taken together their sedative effects can add up, so while they may help relaxation they can also increase drowsiness — avoid combining with sedative medicines or before driving.[22, 24]
Lavender and chamomile are both calming herbs used to ease anxiety and aid sleep; taken together their sedative effects can add up, so while they may help relaxation they can also increase drowsiness — avoid combining with sedative medicines or before driving.[22, 25]
References & Sources
- Fong, H.H.S. and Bauman, J.L (2002) 'Hawthorn', Journal of Cardiovascular Nursing, 16(4), pp. 1-8. doi:10.1097/00005082-200207000-00002 Traditional / reference
https://doi.org/10.1097/00005082-200207000-00002 - Orhan, I.E (2018) 'Phytochemical and Pharmacological Activity Profile of Crataegus oxyacantha L. (Hawthorn) - A Cardiotonic Herb', Current Medicinal Chemistry, 25(37), pp. 4854-4865. doi:10.2174/0929867323666160919095519 Traditional / reference
https://doi.org/10.2174/0929867323666160919095519 - Ahmadipour, B., Kalantar, M., Abaszadeh, S. and Hassanpour, H (2024) 'Antioxidant and antihyperlipidemic effects of hawthorn extract (Crataegus oxyacantha) in broiler chickens', Veterinary Medicine and Science, 10(3), pp. e1414. doi:10.1002/vms3.1414 Preclinical
https://doi.org/10.1002/vms3.1414 - Rigelsky, J.M. and Sweet, B.V (2002) 'Hawthorn: pharmacology and therapeutic uses', American Journal of Health-System Pharmacy, 59(5), pp. 417-422. doi:10.1093/ajhp/59.5.417 Meta-analysis / review
https://doi.org/10.1093/ajhp/59.5.417 - Saeedi, G., Jeivad, F., Goharbari, M., Gheshlaghi, G.H. and Sabzevari, O (2018) 'Ethanol Extract of Crataegus Oxyacantha L. Ameliorate Dietary Non-Alcoholic Fatty Liver Disease in Rat', Drug Research, 68(10), pp. 553-559. doi:10.1055/a-0579-7532 Preclinical
https://doi.org/10.1055/a-0579-7532 - Mecheri, A., Benabderrahmane, W., Amrani, A., Boubekri, N., Benayache, F., Benayache, S. and Zama, D (2019) 'Hepatoprotective Effects of Algerian Crataegus oxyacantha Leaves', Recent Patents on Food, Nutrition & Agriculture, 10(1), pp. 70-75. doi:10.2174/2212798410666180730095456 Preclinical
https://doi.org/10.2174/2212798410666180730095456 - Benabderrahmane, W., Lores, M., Benaissa, O., Lamas, J.P., de Miguel, T., Amrani, A., Benayache, F. and Benayache, S (2019) 'Polyphenolic content and bioactivities of Crataegus oxyacantha L. (Rosaceae)', Natural Product Research, 35(4), pp. 627-632. doi:10.1080/14786419.2019.1582044 Preclinical
https://doi.org/10.1080/14786419.2019.1582044 - Ali, M., Muhammad, S., Shah, M.R., Khan, A., Rashid, U., Farooq, U., Ullah, F., Sadiq, A., Ayaz, M., Ali, M., Ahmad, M. and Latif, A (2017) 'Neurologically Potent Molecules from Crataegus oxyacantha; Isolation, Anticholinesterase Inhibition, and Molecular Docking', Frontiers in Pharmacology, 8, pp. 327. doi:10.3389/fphar.2017.00327 Preclinical
https://doi.org/10.3389/fphar.2017.00327 - Cuevas-Duran, R.E., Medrano-Rodriguez, J.C., Sanchez-Aguilar, M., Soria-Castro, E., Rubio-Ruiz, M.E., Del Valle-Mondragon, L., Sanchez-Mendoza, A., Torres-Narvaez, J.C., Pastelin-Hernandez, G. and Ibarra-Lara, L (2017) 'Extracts of Crataegus oxyacantha and Rosmarinus officinalis Attenuate Ischemic Myocardial Damage by Decreasing Oxidative Stress and Regulating the Production of Cardiac Vasoactive Agents', International Journal of Molecular Sciences, 18(11), pp. 2412. doi:10.3390/ijms18112412 Preclinical
https://doi.org/10.3390/ijms18112412 - Alp, H., Soner, B.C., Baysal, T. and Sahin, A.S (2014) 'Protective effects of Hawthorn (Crataegus oxyacantha) extract against digoxin-induced arrhythmias in rats', Anatolian Journal of Cardiology, 15(12), pp. 970-975. doi:10.5152/akd.2014.5869 Preclinical
https://doi.org/10.5152/akd.2014.5869 - Rothfuss, M.A., Pascht, U. and Kissling, G (2001) 'Effect of long-term application of Crataegus oxyacantha on ischemia and reperfusion induced arrhythmias in rats', Arzneimittel-Forschung, 51(1), pp. 24-28. doi:10.1055/s-0031-1299998 Preclinical
https://doi.org/10.1055/s-0031-1299998 - Khan, A., Akram, M., Thiruvengadam, M., Daniyal, M., Zakki, S.A., Munir, N., Zainab, R., Heydari, M., Mosavat, S.H., Rebezov, M. and Shariati, M.A (2022) 'Anti-anxiety Properties of Selected Medicinal Plants', Current Pharmaceutical Biotechnology, 23(8), pp. 1041-1060. doi:10.2174/1389201022666210122125131 Meta-analysis / review
https://doi.org/10.2174/1389201022666210122125131 - Rastogi, S., Pandey, M.M. and Rawat, A.K.S (2015) 'Traditional herbs: a remedy for cardiovascular disorders', Phytomedicine, 23(11), pp. 1082-1089. doi:10.1016/j.phymed.2015.10.012 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2015.10.012 - European Medicines Agency (2016) 'European Union herbal monograph on Crataegus spp., folium cum flore'. Traditional / reference
https://scholar.google.com/scholar?q=European%20Union%20herbal%20monograph%20on%20Crataegus%20spp.%2C%20folium%20cum%20flore - Hendel, N. and Hendel, M (2014) 'Hedgerow Medicine'. Traditional / reference
https://scholar.google.com/scholar?q=Hedgerow%20Medicine - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure'. Traditional / reference
https://scholar.google.com/scholar?q=Hawthorn%20extract%20for%20treating%20chronic%20heart%20failure - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Tankanow, R., Tamer, H.R., Streetman, D.S., Smith, S.G., Welton, J.L., Annesley, T., Aaronson, K.D. and Bleske, B.E (2003) 'Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha)', Journal of Clinical Pharmacology, 43(6), pp. 637-642. doi:10.1177/0091270003253417 Randomized trial
https://doi.org/10.1177/0091270003253417 - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2 - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
- Tan, L., Liao, F.F., Long, L.Z., Ma, X.C. et al (2023) 'Essential oils for treating anxiety: a systematic review of randomized controlled trials and network meta-analysis', Frontiers in Public Health, 11, pp. 1144404. doi:10.3389/fpubh.2023.1144404 Meta-analysis / review
https://doi.org/10.3389/fpubh.2023.1144404 - Dos Reis Lucena, L., Dos Santos-Junior, J.G., Tufik, S. and Hachul, H (2021) 'Lavender essential oil on postmenopausal women with insomnia: Double-blind randomized trial', Complementary Therapies in Medicine, 59, pp. 102726. doi:10.1016/j.ctim.2021.102726 Randomized trial
https://doi.org/10.1016/j.ctim.2021.102726 - Moss, M., Cook, J., Wesnes, K. and Duckett, P (2003) 'Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults', International Journal of Neuroscience, 113(1), pp. 15-38. doi:10.1080/00207450390161903 Randomized trial
https://doi.org/10.1080/00207450390161903 - Denner, S.S (2009) 'Lavandula angustifolia Miller: English lavender', Holistic Nursing Practice, 23(1), pp. 57-64. doi:10.1097/01.HNP.0000343210.56710.fc Meta-analysis / review
https://doi.org/10.1097/01.HNP.0000343210.56710.fc - Basch, E., Foppa, I., Liebowitz, R., Nelson, J., Smith, M., Sollars, D. and Ulbricht, C (2004) 'Lavender (Lavandula angustifolia Miller)', Journal of Herbal Pharmacotherapy, 4(2), pp. 63-78. doi:10.1080/j157v04n02_07 Meta-analysis / review
https://doi.org/10.1080/j157v04n02_07 - Betlej, I., Andres, B., Cebulak, T., Kapusta, I., Balawejder, M., Zurek, N., Jaworski, S., Lange, A., Kutwin, M., Pisulewska, E., Kidacka, A., Krochmal-Marczak, B., Boruszewski, P. and Borysiuk, P (2024) 'Phytochemical composition and antimicrobial properties of new Lavandula angustifolia ecotypes', Molecules, 29(8), pp. 1740. doi:10.3390/molecules29081740 Preclinical
https://doi.org/10.3390/molecules29081740 - Rahimian, Z., Sadrian, S., Shahisavandi, M., Aligholi, H., Zarshenas, M.M., Abyar, A., Zeraatpisheh, Z. and Asadi-Pooya, A.A (2023) 'Antiseizure effects of Lavandula angustifolia L', BioMed Research International, 2023, pp. 4121998. doi:10.1155/2023/4121998 Preclinical
https://doi.org/10.1155/2023/4121998 - de Melo Alves Silva, L.C., de Oliveira Mendes, F.D.C., de Castro Teixeira, F., de Lima Fernandes, T.E., Barros Ribeiro, K.R., da Silva Leal, K.C., Dantas, D.V. and Neves Dantas, R.A (2023) 'Use of Lavandula angustifolia essential oil as a complementary therapy in adult health care: a scoping review', Heliyon, 9(5), pp. e15446. doi:10.1016/j.heliyon.2023.e15446 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2023.e15446 - Lejeune, V.B.P., Lopes, R.V., Baggio, D.F., Koren, L.D.O., Zanoveli, J.M. and Chichorro, J.G (2023) 'Antinociceptive and anxiolytic-like effects of Lavandula angustifolia essential oil on rat models of orofacial pain', Journal of Applied Oral Science, 30, pp. e20220304. doi:10.1590/1678-7757-2002-0304 Preclinical
https://doi.org/10.1590/1678-7757-2002-0304 - Mykhailenko, O., Hurina, V., Ivanauskas, L., Marksa, M., Skybitska, M., Kovalenko, O., Lytkin, D., Vladymyrova, I. and Georgiyants, V (2024) 'Lavandula angustifolia herb from Ukraine: comparative chemical profile and in vitro antioxidant activity', Chemistry & Biodiversity, 21(9), pp. e202400640. doi:10.1002/cbdv.202400640 Preclinical
https://doi.org/10.1002/cbdv.202400640 - Shamabadi, A. and Akhondzadeh, S (2021) 'Efficacy and tolerability of Lavandula angustifolia in treating patients with the diagnosis of depression: a systematic review of randomized controlled trials', Journal of Complementary & Integrative Medicine, 20(1), pp. 81-91. doi:10.1515/jcim-2020-0498 Meta-analysis / review
https://doi.org/10.1515/jcim-2020-0498 - Cardia, G.F.E., Silva-Filho, S.E., Silva, E.L., Uchida, N.S., Cavalcante, H.A.O., Cassarotti, L.L., Salvadego, V.E.C., Spironello, R.A., Bersani-Amado, C.A. and Cuman, R.K.N (2018) 'Effect of lavender (Lavandula angustifolia) essential oil on acute inflammatory response', Evidence-Based Complementary and Alternative Medicine, 2018, pp. 1413940. doi:10.1155/2018/1413940 Preclinical
https://doi.org/10.1155/2018/1413940 - Aboalhaija, N.H., Syaj, H., Afifi, F., Sunoqrot, S., Al-Shalabi, E. and Talib, W (2022) 'Chemical evaluation, in vitro and in vivo anticancer activity of Lavandula angustifolia grown in Jordan', Molecules, 27(18), pp. 5910. doi:10.3390/molecules27185910 Preclinical
https://doi.org/10.3390/molecules27185910 - Caputo, L., Reguilon, M.D., Minarro, J., De Feo, V. and Rodriguez-Arias, M (2018) 'Lavandula angustifolia essential oil and linalool counteract social aversion induced by social defeat', Molecules, 23(10), pp. 2694. doi:10.3390/molecules23102694 Preclinical
https://doi.org/10.3390/molecules23102694 - European Medicines Agency (HMPC) (2012) 'Community herbal monograph on Lavandula angustifolia Miller, flos'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-lavandula-angustifolia-p-mill-flos_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-lavandula-angustifolia-p-mill-flos_en.pdf - Cavanagh, H.M.A. and Wilkinson, J.M (2002) 'Biological activities of lavender essential oil', 16(4), pp. 301--308. doi:10.1002/ptr.1103 Traditional / reference
https://doi.org/10.1002/ptr.1103 - Lis-Balchin, M (2002) 'Lavender: The Genus Lavandula'. Traditional / reference
https://scholar.google.com/scholar?q=Lavender%3A%20The%20Genus%20Lavandula - Schuwald, A.M. et al (2013) 'Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels', 8(4). doi:10.1371/journal.pone.0059998 Randomized trial
https://doi.org/10.1371/journal.pone.0059998 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003 - Dold, M., Bartova, L., Volz, H.P., Seifritz, E., Moller, H.J., Schlafke, S. and Kasper, S (2023) 'Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials', European Archives of Psychiatry and Clinical Neuroscience, 273(7), pp. 1615-1628. doi:10.1007/s00406-022-01547-w Meta-analysis / review
https://doi.org/10.1007/s00406-022-01547-w - Bent, S., Padula, A., Moore, D., Patterson, M. and Mehling, W (2006) 'Valerian for sleep: a systematic review and meta-analysis', The American Journal of Medicine, 119(12), pp. 1005-1012. doi:10.1016/j.amjmed.2006.02.026 Meta-analysis / review
https://doi.org/10.1016/j.amjmed.2006.02.026 - Haybar, H., Javid, A.Z., Haghighizadeh, M.H., Valizadeh, E., Mohaghegh, S.M. and Mohammadzadeh, A (2018) 'The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina', Clinical Nutrition ESPEN, 26, pp. 47-52. doi:10.1016/j.clnesp.2018.04.015 Randomized trial
https://doi.org/10.1016/j.clnesp.2018.04.015 - Amsterdam, J.D., Li, Y., Soeller, I., Rockwell, K., Mao, J.J. and Shults, J (2009) 'A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder', Journal of Clinical Psychopharmacology, 29(4), pp. 378-382. doi:10.1097/JCP.0b013e3181ac935c Randomized trial
https://doi.org/10.1097/JCP.0b013e3181ac935c
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.